Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -22.66% is 45% above its 5-year average of -40.97%, near the high end of its 5-year range (-89.97%–-22.66%).
As of the fiscal period ended Wednesday, December 31, 2025. 3.29% above its 12-month average of -23.43%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -8.73%.
RETURN ON ASSETS (ROA)
-22.66%
RETURN ON ASSETS (ROA) AVG TTM
-23.43%
RETURN ON ASSETS (ROA) AVG 3Y
-29.30%
RETURN ON ASSETS (ROA) AVG 5Y
-40.97%
RETURN ON ASSETS (ROA) AVG 10Y
-42.45%
RETURN ON ASSETS (ROA) AVG 15Y
-41.94%
RETURN ON ASSETS (ROA) AVG 20Y
-39.41%
CURRENT VS TTM AVG
+3.29%
CURRENT VS 3Y AVG
+22.67%
CURRENT VS 5Y AVG
+44.69%
CURRENT VS 10Y AVG
+46.62%
CURRENT VS 15Y AVG
+45.97%
CURRENT VS 20Y AVG
+42.50%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+29.71%
vs the sector median at left
MDxHealth S.A.
Market Cap
$30.67M
Return on Assets (ROA)
-22.66%
TTM Avg
-23.43%
3Y Avg
-29.30%
5Y Avg
-40.97%
Market Cap
$30.94M
Return on Assets (ROA)
-13.65%
TTM Avg
-19.04%
3Y Avg
-14.35%
5Y Avg
-23.11%
Market Cap
$30.60M
Return on Assets (ROA)
-116.76%
TTM Avg
-76.53%
3Y Avg
-78.60%
5Y Avg
-71.54%
Market Cap
$30.23M
Return on Assets (ROA)
-115.56%
TTM Avg
-181.38%
3Y Avg
-357.07%
5Y Avg
-299.51%
Market Cap
$30.33M
Return on Assets (ROA)
-45.77%
TTM Avg
-31.61%
3Y Avg
-54.99%
5Y Avg
-58.45%
Market Cap
$31.44M
Return on Assets (ROA)
1.29%
TTM Avg
-1.07%
3Y Avg
2.48%
5Y Avg
2.98%
Market Cap
$29.83M
Return on Assets (ROA)
-99.62%
TTM Avg
-39.99%
3Y Avg
-67.06%
5Y Avg
188.84%
Market Cap
$32.08M
Return on Assets (ROA)
-39.14%
TTM Avg
-11.59%
3Y Avg
6.23%
5Y Avg
18.56%
Market Cap
$29.71M
Return on Assets (ROA)
-102.56%
TTM Avg
-232.33%
3Y Avg
-191.42%
5Y Avg
-176.42%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $30.67M | -22.66% | -23.43% | -29.30% | -40.97% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.94M | -13.65% | -19.04% | -14.35% | -23.11% |
| CervoMed Inc. (CRVO)vs › | $30.60M | -116.76% | -76.53% | -78.60% | -71.54% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.23M | -115.56% | -181.38% | -357.07% | -299.51% |
| BeyondSpring Inc. (BYSI)vs › | $30.33M | -45.77% | -31.61% | -54.99% | -58.45% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 1.29% | -1.07% | 2.48% | 2.98% |
| Context Therapeutics Inc. (CNTX)vs › | $29.83M | -99.62% | -39.99% | -67.06% | 188.84% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.08M | -39.14% | -11.59% | 6.23% | 18.56% |
| Quantum Cyber N.V. (QUCY)vs › | $29.71M | -102.56% | -232.33% | -191.42% | -176.42% |
| Rockwell Medical, Inc. (RMTI)vs › | $31.66M | -8.99% | -5.06% | -16.59% | -28.89% |
ROA
-22.7%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -22.66% |
| 2024-12-31 | -24.20% |
| 2023-12-31 | -33.38% |
| 2022-12-31 | -36.97% |
| 2021-12-31 | -38.63% |
| 2020-12-31 | -89.97% |
| 2019-12-31 | -106.08% |
| 2018-12-31 | -49.56% |
| 2017-12-31 | -21.00% |
| 2016-12-31 | -19.45% |
| 2015-12-31 | -25.06% |
| 2014-12-31 | -49.29% |
| 2013-12-31 | -55.05% |
| 2012-12-31 | -59.35% |
| 2011-12-31 | -47.28% |
| 2010-12-31 | -57.24% |
| 2009-12-31 | -57.78% |
| 2008-12-31 | -26.10% |
| 2007-12-31 | -25.00% |
| 2006-12-31 | -20.03% |
| 2005-12-31 | -30.17% |
| 2004-12-31 | -80.34% |
